PROSTATIC ACID PHOSPHATASE (PAP) - ANVISA Registration 80102512984
Access comprehensive regulatory information for PROSTATIC ACID PHOSPHATASE (PAP) in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80102512984 and manufactured by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.. The registration is held by VR MEDICAL IMPORTADORA E DISTRIBUIDORA DE PRODUTOS MÉDICOS LTDA with validity until Mar 27, 2033.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamRelated Devices (2)
Registration Details
80102512984
25351617692202294
04718143000194
Company Information
Dates and Status
Mar 27, 2023
27/03/2033
09/18/2025 19:00:01
PROSTATE-SPECIFIC ANTIGEN (PSA)
Família Maglumi PSA Total (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512976
Mar 06, 2023
PROSTATE-SPECIFIC ANTIGEN (PSA)
Família Maglumi PSA Total (CLIA)
Not specified
80102512976
Mar 06, 2023
PROSTATE-SPECIFIC ANTIGEN (PSA)
FAMÍLIA TPSA (CLIA)
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD
80943610096
Jun 01, 2020
PROSTATE-SPECIFIC ANTIGEN (PSA)
FAMÍLIA TPSA (CLIA)
Not specified
80943610096
Jun 01, 2020
PROSTATE SPECIFIC ANTIGEN (PSA) FREE
MAGLUMI™ f-PSA (CLIA)
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
80102512160
Dec 10, 2018